Atlas Trials

Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis

Clinical trial NCT02943460 · COMPLETED

Trial details

NCT number
NCT02943460
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Sclerosing Cholangitis
Start date
2016-11-29
Primary completion
2018-02-28
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.